Sandoz Partner Samsung Bioepis Settles On Stelara In US

Partners Snag Third-Earliest Launch Date So Far For Biosimilar Ustekinumab

Handshake, striking a deal, settlement
Samsung Bioepis has settled with J&J • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products